In NSCLC, reported incidence of EGFR tissue expression is 43–89% [20] and it has been associated with a worse prognosis [21]; nonetheless, evidence concerning its role as a prognostic factor remains controversial [22-26]. Here, EGFR is linked to non-small cell lung carcinoma.